BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32158290)

  • 1. Pharmacovigilance Perception and Knowledge Among Pharmacists and Interns in Saudi Arabia.
    Alshayban D; Mahmoud MA; Islam MA; Alshammari S; Alsulaiman D
    Risk Manag Healthc Policy; 2020; 13():55-61. PubMed ID: 32158290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug reaction reporting: A National Survey.
    Alkayyal N; Cheema E; Hadi MA
    Curr Pharm Teach Learn; 2017 Sep; 9(5):779-785. PubMed ID: 29233304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
    Khardali A
    Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.
    Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M
    Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia.
    Alwhaibi M; Alhindi G; Alshamrani M; Essa MB; A Al Aloola N; Alhawassi TM
    BMC Med Educ; 2020 Jul; 20(1):210. PubMed ID: 32616054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
    Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 8. A National Survey of Community Pharmacists' Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia.
    Alsheikh MY; Alasmari MM
    Front Pharmacol; 2022; 13():819551. PubMed ID: 35721182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perspective of pharmacist on pharmacovigilance and adverse drug reaction reporting in Asir region, Saudi Arabia.
    Alghazwani Y; Alqahtani AM; Alshuraymi MK; Assiri IM; Shuflut AA; Krishnaraju V; Kumarappan C; Ibrahim ARN; Orayj K
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1667-1680. PubMed ID: 36876701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness, Views, Perceptions, and Beliefs of Pharmacy Interns Regarding Digital Health in Saudi Arabia: Cross-sectional Study.
    Alsahali S
    JMIR Med Educ; 2021 Sep; 7(3):e31149. PubMed ID: 34338649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
    Abdel-Latif MM; Abdel-Wahab BA
    Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.
    Mahmoud MA; Alsowaida Y; Alshammari T; Khan TM; Alrasheedy A; Hassali MA; Aljadhey H
    Saudi Pharm J; 2014 Nov; 22(5):411-8. PubMed ID: 25473329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.
    Sales I; Aljadhey H; Albogami Y; Mahmoud MA
    Saudi Pharm J; 2017 Sep; 25(6):868-872. PubMed ID: 28951672
    [No Abstract]   [Full Text] [Related]  

  • 15. Knowledge and Perception about Pharmacovigilance among Pharmacy Students of Universities in Sana'a Yemen.
    Othman GQ; Ibrahim MIM; Alshakka M; Ansari M; Al-Qadasi F; Halboup AM
    J Clin Diagn Res; 2017 Jun; 11(6):FC09-FC13. PubMed ID: 28764191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study.
    Ahmad A; Patel I; Balkrishnan R; Mohanta GP; Manna PK
    Perspect Clin Res; 2013 Oct; 4(4):204-10. PubMed ID: 24312887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.
    Aljadhey H; Mahmoud MA; Alshammari TM; Al-Dhaeefi M; Le Louet H; Perez-Gutthann S; Pitts PJ
    Saudi Med J; 2015 Sep; 36(9):1097-102. PubMed ID: 26318468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitude and practice of hospital pharmacists towards pharmacovigilance and adverse drug reaction reporting in Najran, Saudi Arabia.
    Alshabi AM; Shaikh MAK; Shaikh IA; Alkahtani SA; Aljadaan A
    Saudi Pharm J; 2022 Jul; 30(7):1018-1026. PubMed ID: 35903528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.